Thyroid disorders are among the most common chronic conditions in the United States, particularly in women. Levothyroxine, the standard treatment for hypothyroidism, is one of the most frequently prescribed medications in the country. If you’re managing a thyroid condition and considering All-on-4 dental implants, it’s a reasonable question to bring to a consultation.
The short version: for patients with well-controlled thyroid disease, dental implants are not contraindicated. A systematic review examining thyroid disorders and dental implants concluded that medically controlled patients with either hypothyroidism or hyperthyroidism are not at a higher risk of implant failure than patients without thyroid disease.
That said, the two conditions affect bone and healing in different ways, and understanding those differences matters when planning treatment.
How the thyroid affects bone
Thyroid hormones play a direct role in bone metabolism. They regulate the activity of osteoblasts, which build bone, and osteoclasts, which break it down. When thyroid function is disrupted in either direction, bone health is affected, but the mechanism differs depending on whether the thyroid is overactive or underactive.
This matters for dental implants because osseointegration, the process by which an implant fuses with the jawbone, depends on healthy bone that can remodel and heal normally. Anything that disrupts bone metabolism creates considerations for how implant treatment is planned and monitored.
Hypothyroidism and dental implants
Hypothyroidism slows bone turnover by reducing the recruitment, maturation, and activity of bone cells. Both osteoblastic bone formation and osteoclastic bone resorption decrease, resulting in a lower overall rate of bone remodeling. This can affect bone quality and the pace of healing after surgery.
The most clinically relevant study on this topic examined 27 hypothyroid women on replacement therapy against a matched control group. There was no statistically significant difference in implant failure rates between the two groups (5% vs 3%). The hypothyroid patients did show more soft tissue complications after stage one surgery (22% vs 8.6%), and slightly more bone loss around implants after the first year of loading.
A case series of 17 dental implants placed in T4-treated hypothyroid patients found that all implants met the criteria for success at one-year follow-up, with median crestal bone loss of 0.6 mm at 6 to 12 months after loading.
The consistent finding across the literature is that controlled hypothyroidism is a relative consideration, not an absolute barrier. What it does mean in practice: the implant specialist should be aware of potential differences in soft tissue healing; bone quality may be lower than in a healthy patient; and post-placement monitoring should account for the slightly elevated peri-implant bone loss risk over time.
One complication worth flagging is the T4 replacement therapy itself. Several studies have found that levothyroxine at higher doses is associated with reduced bone mineral density at certain skeletal sites, an effect that can occur even in patients who appear clinically well controlled. Approximately 45% of patients on levothyroxine are estimated to be either over- or under-treated at any given time. If your thyroid levels haven’t been checked recently, getting current labs before a dental implant consultation is worth doing.
Hyperthyroidism and dental implants
Hyperthyroidism creates the opposite bone problem. Excess thyroid hormone accelerates bone turnover, with resorption outpacing formation. Overt hyperthyroidism is an established cause of high bone turnover with accelerated bone loss, leading to osteoporosis and increased fracture risk. Even subclinical hyperthyroidism, where TSH is suppressed, but thyroid hormones are within the reference range, has been linked to decreased bone mineral density and increased fracture risk, particularly in postmenopausal women.
For dental implants, the main concern with active or poorly controlled hyperthyroidism is that accelerated bone resorption creates a less stable foundation for osseointegration. The severity and duration of the hyperthyroid state matter: research shows that the longer thyrotoxicosis persists, the greater the impact on bone turnover markers and bone mineral density.
The practical implication: hyperthyroid patients with active, uncontrolled disease are not good implant candidates. Hyperthyroid patients who are well-treated and have reached a stable euthyroid state (normal thyroid function, confirmed by labs) are in a very different position, and the same systematic review that covers hypothyroidism applies here: controlled hyperthyroid patients show implant survival rates comparable to those of healthy controls.
Graves’ disease, the most common cause of hyperthyroidism, is worth noting specifically. Because it’s autoimmune in nature, it can also affect the immune response and healing in ways that a purely endocrine assessment might underestimate. Your dental specialist should be able to determine whether Graves’ disease is the underlying cause.
The over-replacement problem
One issue that applies to patients on levothyroxine and doesn’t always get enough attention is TSH-suppressive dosing. Patients treated for thyroid cancer are often maintained on doses of levothyroxine high enough to suppress TSH below normal levels, as part of their cancer management protocol. This creates a state of iatrogenic (medically induced) subclinical hyperthyroidism, with the same bone consequences: accelerated bone loss over time.
If you’re on a TSH-suppressive dose of levothyroxine rather than a replacement dose, that distinction is clinically relevant to implant planning and worth discussing with both your endocrinologist and your dental specialist.
What to bring to a consultation
For any patient with a thyroid disorder considering All-on-4, a few things should come to the consultation:
Your most recent thyroid function labs, including TSH, T3, and T4. The name of your current medication and dose. Whether your thyroid condition is the result of Hashimoto’s thyroiditis, Graves’ disease, surgical removal, or another cause. Any history of osteoporosis or bone density testing.
Your dental specialist should factor thyroid status into the imaging evaluation and any bone grafting decisions, and if your labs are recent, getting them updated before treatment starts is sensible.
Questions worth asking at your consultation
- Is my current thyroid function well enough controlled to proceed with implant placement?
- Should my endocrinologist be informed before surgery?
- Does my medication type or dose affect bone quality or healing expectations?
- Based on my imaging, does my bone volume and density support standard placement, or will adjustments be needed?
- What does post-placement monitoring look like for thyroid patients?
The bottom line
Thyroid disorders are common, and many patients with hypothyroidism or well-treated hyperthyroidism receive dental implants with outcomes comparable to those without thyroid disease. The key factors are disease control and current thyroid function, not the diagnosis itself.
Poorly controlled or untreated thyroid disease is a different story. Active hyperthyroidism with ongoing bone loss, or significantly undertreated hypothyroidism with impaired healing both warrant stabilization before implant treatment is considered.
If your thyroid condition is managed and your levels are in a healthy range, the conversation about All-on-4 is worth having.
At All-on-Four Dental Implant Centers, we work with patients managing thyroid conditions and a wide range of other systemic health considerations. To find out where you stand, call us at (833) 454-4579 or request a consultation online.